🕵️ TELA BIO, Inc. ($TELA)
SEC insider & ownership activity, last 12 months · CIK 1561921 · every row links its SEC filing
Over the last 12 months insiders bought $4.0M with no open-market selling against it. EW Healthcare Partners Fund 2, L.P. bought $4.0M in discretionary trades (Nov). Lytton, Laurence W. trimmed 7.2% → 5.5%. One red-flag 8-K in the window: Delisting notice (3.01), Mar 17, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $4.0M (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| EW Healthcare Partners Fund 2, L.P. | 1 | $4.0M | 0 | – | Nov 17, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| EW Healthcare Partners Fund 2 GP, L.P. | 17.3% | 13G | Nov 17, 2025 | filing ↗ | |
| EW Healthcare Partners Fund 2-GP, L.P. | 17.2% | 13D | Jun 9, 2026 | filing ↗ | |
| EW Healthcare Partners Fund 2-UGP, LLC | 17.2% | 13D | Jun 9, 2026 | filing ↗ | |
| Nantahala Capital Management, LLC | 12.9% | 13G | May 7, 2025 | filing ↗ | |
| Wilmot B. Harkey | 12.9% | 13G | May 7, 2025 | filing ↗ | |
| Daniel Mack | 12.9% | 13G | May 7, 2025 | filing ↗ | |
| EW Healthcare Partners Fund 2-A, L.P. | 10.5% | 13D | Jun 9, 2026 | filing ↗ | |
| North RUN Capital, LP | 9.3% | 13G | May 30, 2025 | filing ↗ | |
| North RUN Advisors, LLC | 9.3% | 13G | May 30, 2025 | filing ↗ | |
| North RUN - DUE North Partners, LP | 9.3% | 13G | May 30, 2025 | filing ↗ | |
| North RUN GP, LP | 9.3% | 13G | May 30, 2025 | filing ↗ | |
| Todd B. Hammer | 9.3% | 13G | May 30, 2025 | filing ↗ | |
| Thomas B. Ellis | 9.3% | 13G | May 30, 2025 | filing ↗ | |
| Michael Bosco | 9.3% | 13G | May 30, 2025 | filing ↗ | |
| Silverarc Capital Management, LLC | 7.8% | 13G | Feb 12, 2025 | filing ↗ | |
| Devesh S. Gandhi | 7.8% | 13G | Feb 12, 2025 | filing ↗ | |
| EW Healthcare Partners Fund 2, L.P. | 6.8% | 13D | Jun 9, 2026 | filing ↗ | |
| Stonepine Capital Management, LLC | 6.0% | 13G | Feb 13, 2025 | filing ↗ | |
| Stonepine Capital, L.P. | 6.0% | 13G | Feb 13, 2025 | filing ↗ | |
| Stonepine GP, LLC | 6.0% | 13G | Feb 13, 2025 | filing ↗ | |
| Jon M. Plexico | 6.0% | 13G | Feb 13, 2025 | filing ↗ | |
| Lytton, Laurence W. | 5.5% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 9, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | Apr 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 29, 2026 | filing ↗ |
| Earnings (2.02) | Mar 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 17, 2026 | filing ↗ |
| Material agreement (1.01) | Nov 13, 2025 | filing ↗ |
| Agreement terminated (1.02) | Nov 13, 2025 | filing ↗ |
| New financial obligation (2.03) | Nov 13, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 31, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 4, 2025 | filing ↗ |
| Earnings (2.02) | Aug 11, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2025 | filing ↗ |